CNS Neuroscience & Therapeutics,
Journal Year:
2023,
Volume and Issue:
29(11), P. 3446 - 3459
Published: June 2, 2023
Traumatic
brain
injury
(TBI)
is
a
leading
cause
of
long-term
disability
in
young
adults
and
induces
complex
neuropathological
processes.
Cellular
autonomous
intercellular
changes
during
the
subacute
phase
contribute
substantially
to
neuropathology
TBI.
However,
underlying
mechanisms
remain
elusive.
In
this
study,
we
explored
dysregulated
cellular
signaling
TBI.Single-cell
RNA-sequencing
data
(GSE160763)
TBI
were
analyzed
explore
cell-cell
communication
Upregulated
neurotrophic
factor
was
validated
mouse
model
Primary
cell
cultures
lines
used
as
vitro
models
examine
potential
affecting
signaling.Single-cell
analysis
revealed
that
microglia
astrocytes
most
affected
cells
Cell-cell
demonstrated
mediated
by
non-canonical
factors
midkine
(MDK),
pleiotrophin
(PTN),
prosaposin
(PSAP)
microglia/astrocytes
upregulated
Time-course
profiling
showed
MDK,
PTN,
PSAP
expression
primarily
TBI,
major
source
MDK
PTN
after
studies
enhanced
activated
microglia.
Moreover,
promoted
proliferation
neural
progenitors
derived
from
human-induced
pluripotent
stem
(iPSCs)
neurite
growth
iPSC-derived
neurons,
whereas
exclusively
stimulated
growth.The
played
crucial
role
neuroregeneration.
Brain Behavior and Immunity,
Journal Year:
2020,
Volume and Issue:
91, P. 740 - 755
Published: Oct. 8, 2020
Central
nervous
system
(CNS)
innate
immunity
plays
essential
roles
in
infections,
neurodegenerative
diseases,
and
brain
or
spinal
cord
injuries.
Astrocytes
microglia
are
the
principal
cells
that
mediate
CNS.
Pattern
recognition
receptors
(PRRs),
expressed
by
astrocytes
microglia,
sense
pathogen-derived
endogenous
ligands
released
damaged
initiate
immune
response.
Toll-like
(TLRs)
a
well-characterized
family
of
PRRs.
The
contribution
microglial
TLR
signaling
to
CNS
pathology
has
been
extensively
investigated.
Even
though
assume
wide
variety
key
functions,
information
about
role
astroglial
TLRs
disease
injuries
is
limited.
Because
display
heterogeneity
exhibit
phenotypic
plasticity
depending
on
effectors
present
local
milieu,
they
can
exert
both
detrimental
beneficial
effects.
modulators
these
paradoxical
properties.
goal
current
review
highlight
played
diseases.
We
discuss
host
defense
as
well
dissemination
viral
bacterial
infections
examine
link
between
pathogenesis
diseases
evidence
showing
pivotal
influence
sterile
inflammation
injury.
Finally,
we
define
research
questions
areas
warrant
further
investigations
context
astrocytes,
TLRs,
dysfunction.
Frontiers in Neuroscience,
Journal Year:
2023,
Volume and Issue:
17
Published: Feb. 23, 2023
Traumatic
brain
injury
(TBI)
results
when
external
physical
forces
impact
the
head
with
sufficient
intensity
to
cause
damage
brain.
TBI
can
be
mild,
moderate,
or
severe
and
may
have
long-term
consequences
including
visual
difficulties,
cognitive
deficits,
headache,
pain,
sleep
disturbances,
post-traumatic
epilepsy.
Disruption
of
normal
functioning
leads
a
cascade
effects
molecular
anatomical
changes,
persistent
neuronal
hyperexcitation,
neuroinflammation,
loss.
Destructive
processes
that
occur
at
cellular
level
lead
inflammation,
oxidative
stress,
calcium
dysregulation,
apoptosis.
Vascular
damage,
ischemia
loss
blood
barrier
integrity
contribute
destruction
tissue.
This
review
focuses
on
incited
during
frequently
life-altering
lasting
this
vision,
cognition,
balance,
sleep.
The
wide
range
complaints
associated
are
addressed
repair
where
there
is
potential
for
intervention
preservation
highlighted.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(12), P. 6418 - 6418
Published: June 15, 2021
Traumatic
brain
injury
(TBI)
is
immediate
damage
caused
by
a
blow
to
the
head
resulting
from
traffic
accidents,
falls,
and
sporting
activity,
which
causes
death
or
serious
disabilities
in
survivors.
TBI
induces
multiple
secondary
injuries,
including
neuroinflammation,
disruption
of
blood–brain
barrier
(BBB),
edema.
Despite
these
emergent
conditions,
current
therapies
for
are
limited
insufficient
some
cases.
Although
several
candidate
drugs
exerted
beneficial
effects
animal
models,
most
them
failed
show
significant
clinical
trials.
Multiple
studies
have
suggested
that
astrocytes
play
key
role
pathogenesis
TBI.
Increased
reactive
astrocyte-derived
factors
commonly
observed
both
patients
experimental
models.
Astrocytes
detrimental
on
TBI,
promotion
restriction
neurogenesis
synaptogenesis,
acceleration
suppression
repair
BBB
via
bioactive
factors.
Additionally,
astrocytic
aquaporin-4
involved
formation
cytotoxic
Thus,
attractive
targets
novel
therapeutic
although
astrocyte-targeting
not
yet
been
developed.
This
article
reviews
recent
observations
roles
expected
Frontiers in Cell and Developmental Biology,
Journal Year:
2021,
Volume and Issue:
9
Published: June 9, 2021
Hepatocyte
growth
factor
(HGF)
and
its
tyrosine
kinase
receptor,
encoded
by
the
MET
cellular
proto-oncogene,
are
expressed
in
nervous
system
from
pre-natal
development
to
adult
life,
where
they
involved
neuronal
survival.
In
this
review,
we
highlight,
beyond
neurotrophic
action,
novel
roles
of
HGF-MET
synaptogenesis
during
post-natal
brain
connection
between
deregulation
expression
developmental
disorders
such
as
autism
spectrum
disorder
(ASD).
On
pharmacology
side,
HGF-induced
activation
exerts
beneficial
neuroprotective
effects
also
adulthood,
specifically
neurodegenerative
disease,
preclinical
models
cerebral
ischemia,
spinal
cord
injuries,
neurological
pathologies,
Alzheimer's
disease
(AD),
amyotrophic
lateral
sclerosis
(ALS),
multiple
(MS).
HGF
is
a
key
preventing
death
promoting
survival
through
pro-angiogenic,
anti-inflammatory,
immune-modulatory
mechanisms.
Recent
evidence
suggests
that
acts
on
neural
stem
cells
enhance
neuroregeneration.
The
possible
therapeutic
application
mimetics
for
treatment
discussed.
Journal of Neurotrauma,
Journal Year:
2021,
Volume and Issue:
38(11), P. 1535 - 1550
Published: March 31, 2021
Exosomes
play
an
important
role
in
intercellular
communication
by
delivering
microribonucleic
acids
(miRNAs)
to
recipient
cells.
Previous
studies
have
demonstrated
that
multi-potent
mesenchymal
stromal
cell
(MSC)-derived
exosomes
improve
functional
recovery
after
experimental
traumatic
brain
injury
(TBI).
This
study
was
performed
determine
efficacy
of
miR-17-92
cluster-enriched
(Exo-17-92)
harvested
from
human
bone
marrow
MSCs
transfected
with
a
cluster
plasmid
enhancing
tissue
and
neurological
compared
derived
empty
vector
(Exo-empty)
for
treatment
TBI.
Adult
male
rats
underwent
unilateral
moderate
cortical
contusion.
Animals
received
single
intravenous
injection
(100
μg/rat,
approximately
3.75x1011
particles,
Exo-17-92)
or
control
Exo-empty)
Vehicle
(phosphate-buffered
solution)
one
day
injury.
A
battery
tests
weekly
TBI
five
weeks.
Spatial
learning
memory
were
measured
on
days
31-35
using
the
Morris
water
maze
test.
All
animals
sacrificed
weeks
Their
brains
processed
histopathological
immunohistochemical
analyses
lesion
volume,
loss,
angiogenesis,
neurogenesis,
neuroinflammation.
Compared
Vehicle,
both
Exo-17-92
Exo-empty
treatments
significantly
improved
sensorimotor
cognitive
function,
reduced
neuroinflammation
hippocampal
neuronal
promoted
angiogenesis
neurogenesis
without
altering
volume.
Moreover,
exhibited
more
robust
therapeutic
effect
improvement
reducing
than
did
treatment.
enriched
better
improving
Exo-empty,
likely
endogenous
neurogenesis.
Engineering
specific
miRNA
may
provide
novel
strategy
management
contusion
Biology,
Journal Year:
2023,
Volume and Issue:
12(10), P. 1307 - 1307
Published: Oct. 3, 2023
Microglial
and
astrocytic
reactivity
is
a
prominent
feature
of
amyotrophic
lateral
sclerosis
(ALS).
Microglia
astrocytes
have
been
increasingly
appreciated
to
play
pivotal
roles
in
disease
pathogenesis.
These
cells
can
adopt
distinct
states
characterized
by
specific
molecular
profile
or
function
depending
on
the
different
contexts
development,
health,
aging,
disease.
Accumulating
evidence
from
ALS
rodent
cell
models
has
demonstrated
neuroprotective
neurotoxic
functions
microglia
astrocytes.
In
this
review,
we
focused
recent
advancements
knowledge
microglial
nomenclature,
landmark
discoveries
demonstrating
clear
contribution
pathogenesis,
novel
therapeutic
candidates
leveraging
these
that
are
currently
undergoing
clinical
trials.
Journal of Neuroinflammation,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: May 10, 2024
Abstract
Traumatic
brain
injury
(TBI)
is
a
chronic
and
debilitating
disease,
associated
with
high
risk
of
psychiatric
neurodegenerative
diseases.
Despite
significant
advancements
in
improving
outcomes,
the
lack
effective
treatments
underscore
urgent
need
for
innovative
therapeutic
strategies.
The
brain-gut
axis
has
emerged
as
crucial
bidirectional
pathway
connecting
gastrointestinal
(GI)
system
through
an
intricate
network
neuronal,
hormonal,
immunological
pathways.
Four
main
pathways
are
primarily
implicated
this
crosstalk,
including
systemic
immune
system,
autonomic
enteric
nervous
systems,
neuroendocrine
microbiome.
TBI
induces
profound
changes
gut,
initiating
unrestrained
vicious
cycle
that
exacerbates
axis.
Alterations
gut
include
mucosal
damage
malabsorption
nutrients/electrolytes,
disintegration
intestinal
barrier,
increased
infiltration
cells,
dysmotility,
dysbiosis,
enteroendocrine
cell
(EEC)
dysfunction
disruption
(ENS)
(ANS).
Collectively,
these
further
contribute
to
neuroinflammation
neurodegeneration
via
gut-brain
In
review
article,
we
elucidate
roles
various
anti-inflammatory
pharmacotherapies
capable
attenuating
dysregulated
inflammatory
response
along
TBI.
These
agents
hormones
such
serotonin,
ghrelin,
progesterone,
ANS
regulators
beta-blockers,
lipid-lowering
drugs
like
statins,
flora
modulators
probiotics
antibiotics.
They
attenuate
by
targeting
distinct
both
post-TBI.
exhibit
promising
potential
mitigating
inflammation
enhancing
neurocognitive
outcomes
patients.
Anatomical Science International,
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 13, 2024
Abstract
Traumatic
brain
injuries
(TBI)
commonly
occur
following
head
trauma.
TBI
may
result
in
short-
and
long-term
complications
which
lead
to
neurodegenerative
consequences,
including
cognitive
impairment
post-TBI.
When
investigating
the
neurodegeneration
TBI,
studies
have
highlighted
role
reactive
astrocytes
neuroinflammation
degeneration
process.
This
review
showcases
a
variety
of
markers
that
show
astrocyte
presence
under
pathological
conditions,
glial
fibrillary
acidic
protein
(GFAP),
Crystallin
Alpha-B
(CRYA-B),
Complement
Component
3
(C3)
S100A10.
Astrocyte
activation
white-matter
inflammation,
expressed
as
hyperintensities.
Other
changes
include
increased
cortical
thickness
white
matter.
addresses
gaps
literature
regarding
post-mortem
human
focussing
on
astrocytes,
alongside
potential
uses
these
proteins
future
investigate
proportions
post-TBI
has
been
discussed.
research
benefit
focus
play
assist
clinicians
managing
patients
who
suffered
TBI.
Cells,
Journal Year:
2024,
Volume and Issue:
13(2), P. 148 - 148
Published: Jan. 12, 2024
Traumatic
Brain
Injury
(TBI)
represents
a
significant
health
concern,
necessitating
advanced
therapeutic
interventions.
This
detailed
review
explores
the
critical
roles
of
astrocytes,
key
cellular
constituents
central
nervous
system
(CNS),
in
both
pathophysiology
and
possible
rehabilitation
TBI.
Following
injury,
astrocytes
exhibit
reactive
transformations,
differentiating
into
pro-inflammatory
(A1)
neuroprotective
(A2)
phenotypes.
paper
elucidates
interactions
with
neurons,
their
role
neuroinflammation,
potential
for
exploitation.
Emphasized
strategies
encompass
utilization
endocannabinoid
calcium
signaling
pathways,
hormone-based
treatments
like
17β-estradiol,
biological
therapies
employing
anti-HBGB1
monoclonal
antibodies,
gene
therapy
targeting
Connexin
43,
innovative
technique
astrocyte
transplantation
as
means
to
repair
damaged
neural
tissues.